procarbazine has been researched along with Di Guglielmo Disease in 2 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mantovani, G | 1 |
| Del Giacco, GS | 1 |
| Marongiu, F | 1 |
| Tognella, S | 1 |
| Carassi, UE | 1 |
| Steel, NR | 1 |
| Carr, D | 1 |
| Finney, RD | 1 |
2 other studies available for procarbazine and Di Guglielmo Disease
| Article | Year |
|---|---|
Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Leukemia, Er | 1982 |
Erythroleukaemia following treatment of Hodgkin's disease.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combinati | 1982 |